Pathalys Pharma is a biopharmaceutical company developing advanced therapeutics for end-stage kidney disease (ESKD).

Arialys Therapeutics is a biotechnology company that develops precision medicines to target pathogenic autoantibodies in the central nervous system, with a focus on treating neuropsychiatric diseases caused by autoimmunity.